News
HOUSTON, April 22, 2025 /PRNewswire/ -- New findings published today in NEJM Evidence reveal promising clinical outcome for Cellenkos Inc.'s cryopreserved, allogeneic, T regulatory (Treg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback